E-LIB Suche - Ergebnisse für: Ettl, Johannes - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Update breast cancer 2023 Part 1: early stage breast cancer:

Hartkopf, Andreas D ; Fehm, Tanja N ; Welslau, Manfred...
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/112502. , 2023

Link: https://opus.bibliothek...

2

Trastuzumab deruxtecan versus treatment of physician's choi..:

André, Fabrice ; Hee Park, Yeon ; Kim, Sung-Bae...
The Lancet, Vol.401 No.10390, pp.1773-1785. , 2023

Link: https://hdl.handle.net/1..

3

Heregulin (HRG) assessment for clinical trial eligibility t..:

Huebner, Hanna ; Kurbacher, Christian M ; Kuesters, Geoffrey...
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-07546-1#Sec17. , 2023

Link: https://doi.org/10.18725..

4

Genomic analysis of advanced breast cancer tumors from tala..:

Turner, Nicholas ; Laird, A. Douglas ; Telli, Melinda...
npj Breast Cancer;9. , 2023

Link: https://hdl.handle.net/1..

5

Trastuzumab deruxtecan versus treatment of physician's choi..:

André, Fabrice ; Hee Park, Yeon ; Kim, Sung-Bae...
boreal:274940. , 2023

Link: http://hdl.handle.net/20..

6

Update breast cancer 2023 part 2: advanced-stage breast can..:

Lux, Michael P ; Hartkopf, Andreas D ; Fehm, Tanja N...
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/112521. , 2023

Link: https://opus.bibliothek...

7

Trastuzumab deruxtecan versus treatment of physician's choi..:

André, Fabrice ; Hee Park, Yeon ; Kim, Sung-Bae...
boreal:274940. , 2023

Link: http://hdl.handle.net/20..

8

Genomic analysis of advanced breast cancer tumors from tala..:

Turner, Nicholas ; Laird, A ; Telli, Melinda...
qt1th3k3nh. , 2023

Link: https://escholarship.org..

9

Determinants of Response to Talazoparib in Patients with HE..:

Blum, Joanne L ; Laird, A. Douglas ; Litton, Jennifer K...
https://mediatum.ub.tum.de/1740230. , 2022

Link: https://mediatum.ub.tum...

10

Clinical effectiveness of olaparib monotherapy in germline ..:

Gelmon, Karen A ; Fasching, Peter A ; Couch, Fergus J...
European Journal of Cancer, Vol.152, pp.68-77. , 2022

Link: https://hdl.handle.net/1..

11

Progression-Free Survival and Overall Survival in Patients ..:

Michel, Laura L ; Hartkopf, Andreas D ; Fasching, Peter A...
http://dx.doi.org/10.18725/OPARU-42471. , 2022

Link: https://doi.org/10.18725..

12

Determinants of Response to Talazoparib in Patients with HE..:

Blum, Joanne L ; Laird, A Douglas ; Litton, Jennifer K...
qt58m8w083. , 2022

Link: https://escholarship.org..

13

Challenges and Opportunities for Real-World Evidence in Met..:

Lüftner, Diana ; Hartkopf, Andreas D ; Lux, Michael P...
https://mediatum.ub.tum.de/1624207. , 2021

Link: https://mediatum.ub.tum...

14

Progression-Free Survival and Overall Survival in Patients ..:

Michel, Laura L ; Hartkopf, Andreas D ; Fasching, Peter A...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/15194. , 2020

Link: https://opus4.kobv.de/op..

15

Initial experience with CDK4/6 inhibitor-based therapies co..:

Schneeweiss, Andreas ; Ettl, Johannes ; Lüftner, Diana...
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/15590. , 2020

Link: https://opus4.kobv.de/op..

1-15